nox-a12
noxxon
['biomarker', 'gloria']
|live| #biomarker data from gloria now presented at #asco23! poster reveals that high frequency of endothelial (e12)/glioma (g12) cells expressing our target cxcl12 - #eg12score - is predictive for clinical response to #noxa12 therapy in #glioblastoma 
TME Pharma's #Spiegelmer platform has generated a pipeline of cancer compounds targeting the tumor microenvironment (TME). TME Pharma is listed on Euronext.